Skip to main content
Equibles

CAPTRUST FINANCIAL ADVISORS

Position in DYAI — Dyadic International Inc

CIK 1512024 RALEIGH, NC
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,500
+$1,200 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 39 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $169,003,876 across 125 Biotechnology names. DYAI ranks #117 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 36,464 $22,736,762
2 RPRX
Royalty Pharma plc
 337,298 $18,912,298
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 35,471 $17,619,509
4 EXEL
Exelixis, Inc.
 303,042 $16,488,515
5 LGND
Ligand Pharmaceuticals Inc
 34,607 $10,938,926
6 HALO
Halozyme Therapeutics, Inc.
 125,946 $9,857,793
7 CELC
Celcuity Inc.
 71,445 $7,474,575
8 INCY
Incyte Corp
 50,301 $5,702,121

All Filings in DYAI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,500 15,000
2026-03-31 $12,300 15,000
2025-12-31 $14,100 15,000
2025-09-30 $17,700 15,000
2025-06-30 $14,850 15,000
2025-03-31 $20,250 15,000
2024-12-31 $26,250 15,000
2024-09-30 $15,600 15,000
2024-06-30 $22,200 15,000
2024-03-31 $25,050 15,000
2023-12-31 $24,150 15,000
2023-09-30 $28,800 15,000
2023-06-30 $28,950 15,000
2023-03-31 $26,700 15,000
2022-09-30 $28,650 15,000
2022-06-30 $45,750 15,000
2022-03-31 $45,150 15,000